Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.
Czupryniak
Aneta
A
Department of Nephrology and Dialysis, Polish Mother's Memorial Hospital Research Institute, Łódz, Poland. aczupryniak@wp.pl
Kałuzyńska
Anna
A
Nowicki
Michał
M
Wiecek
Bogusław
B
Bald
Edward
E
Owczarek
Danuta
D
D000293:Adolescent; D000328:Adult; D019332:Endothelin-1 / Q000097:blood*; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006225:Hand / Q000098:blood supply / Q000473:pathology; D006710:Homocysteine / Q000097:blood; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011928:Raynaud Disease / Q000097:blood* / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D006435:Renal Dialysis / Q000009:adverse effects; D014841:von Willebrand Factor / Q000032:analysis
D019332:Endothelin-1; D014841:von Willebrand Factor; D006710:Homocysteine